A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

Clinical trial NCT07265921 · RECRUITING

Trial details

NCT number: NCT07265921
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Cancer

Start date: 2025-11-07
Primary completion: 2028-12-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.